AZN News and Press, AstraZeneca PLC From 02/26/24

Alexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign Canada NewsWire In recognition of Rare Disease Day on February 29 , Alexion welcomes people across the country to join the international colourUp4RARE challenge and learn more ab...

2024-02-26 05:46:32 ET Read the full article on Seeking Alpha For further details see: AstraZeneca gets EU backing for blood disorder add-on therapy

2024-02-25 12:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Phase 3 data for As...

2024-02-24 20:53:46 ET Summary Topline 36-week data from the phase 2 ALPACAR-360 study using its drug zerlasiran for patients with high lipoprotein[a] and stable atherosclerotic cardiovascular disease, expected in Q1 2024. There are four other data readouts/presentations expected ...

2024-02-23 17:58:23 ET Summary Ionis Pharmaceuticals, Inc. reported Q4 2023 earnings this week - revenues increased 34% year-on-year to $788m, comfortably outperforming management's guidance. The stock price of Ionis has dipped in 2024 after a lengthy bull run - current market cap...

2024-02-23 15:25:33 ET More on AstraZeneca AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss AstraZeneca PLC 2023 Q4 - Results - Earnings Call Presentation Sodexo, AstraZeneca ex...

FASENRA enabled patients to taper off oral corticosteroids while preventing relapses Positive results from the MANDARA Phase III trial for FASENRA ® (benralizumab) in patients with EGPA were published in the New England Journal of Medicine today, 1 as the fi...

2024-02-22 21:01:24 ET Summary Novo Nordisk had a near perfect FY23. Fundamentally, FY24 should look quite similar. In reviewing FY23 results and commentary, we discuss key points like SELECT outcomes; CagriSema progress; and expansion into cardiovascular disease. Though expen...

2024-02-22 14:41:34 ET More on Amgen, Eli Lilly, etc. Pfizer's Post-Pandemic Pivot Pfizer: Turnaround Is Gaining Momentum Eli Lilly: Yes, It Is Too Late To Join The Party Novo to face Wegovy competition in India as local versions loom: Reuters Weight-...

2024-02-21 11:51:31 ET Summary AstraZeneca PLC has announced a deal to acquire Gracell Biotechnologies Inc., a Chinese company focused on developing cell therapies for cancer and autoimmune diseases. The terms of the acquisition include a cash payment of $10 per Gracell ADR and a ...